News

This month’s case looks at whether being part of a state’s comprehensive medical marijuana program qualifies the user as a ...
Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.
Poor communication contributed to 24.0% of safety incidents in 42 studies that examined its contribution along with other causes.
ANAC hosted guest speaker Lindsey Dawson to address potential cuts to federal HIV prevention funding and what outcomes providers should expect.
The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.
A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...
The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.
The AHA has published a scientific statement regarding cardiovascular toxicity in patients with history of treatment for childhood cancer.
The NIH spends more than $300 million each year studying autism. It’s not clear how Kennedy’s new study will differ, and HHS has not released further details.
Short-term outcomes for epileptic patients improved following the new International League Against Epilepsy definition and diagnosis criteria. HealthDay News — The new International League ...
The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...